Deepa Diaram
Podiatrist · Seaford, DENPI 1083994305
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Smith+Nephew at 53.2% of the total. Reporting peaked in 2019 at $376 and has fallen 95.1% since, to $18 in 2025. That places this record below the midpoint for podiatrist clinicians in DE, where the typical reported total is $1,099.
Across 54 payments — averaging $14.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$406
- Osiris Therapeutics Inc.$82
- Integra Lifesciences Corporation$46
- Kerecis Limited$37
- Organogenesis Inc.$32
- Medela LLC$29
- plus $131 from 7 others
What the payments were for
- Food & beverage$763100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 35 | $406 |
| Osiris Therapeutics Inc. | 3 | $82 |
| Integra Lifesciences Corporation | 3 | $46 |
| Kerecis Limited | 2 | $37 |
| Organogenesis Inc. | 2 | $32 |
| Medela LLC | 2 | $29 |
| Abbott | 1 | $24 |
| Pfizer | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $20 |
| Hartmann USA, Inc. | 1 | $20 |
| Lifenet Health | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
How this compares
$763 in reported general payments places this provider in the 40th percentile of 37 podiatrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 36 | $772 |
| Ketoconazole | 32 | $646 |
| Terbinafine Hcl | 19 | $428 |
| Ammonium Lactate | 16 | $364 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $349 |
| Gabapentin | 38 | $321 |
| Methylprednisolone | 18 | $103 |
| Doxycycline Hyclate | 15 | $71 |
| Cephalexin | 17 | $60 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Seaford
- Joseph BrownSeaford$2K
- Jennifer SeifertNewark$12K
- Harold GruberWilmington$10K
- Lahari MadulapallyWilmington$9K
- Jason KlineNewark$9K
- Matthew WaxmanMiddletown$7K
- Brian McDermottWilmington$7K
- Dimitrios MoustakasSmyrna$7K
- James BrayNewark$7K
- Joseph WendolowskiLewes$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.